Ascletis Pharma Inc.
1672
Kedudukan dalam Saham
#10608
Ascletis Pharma Inc., a biotechnology company, engages in the research and... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
Harga Saham
$0.7330173
Modal Pasaran
$769.42M
Perubahan (1 hari)
-2.05%
Perubahan (1 tahun)
-39.92%
Negara
CN
Perdagangan Ascletis Pharma Inc. (1672)
Kategori
Healthcare
Sejarah pecahan saham untuk Ascletis Pharma Inc. (1672)
Saham Ascletis Pharma Inc. (simbol: 1672) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham 1672 yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham 1672.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham 1672 yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham 1672.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
